ZNF239 Activators
ZNF239 activators encompass a diverse array of compounds that exert their effects through various signaling pathways, ultimately leading to the modulation of ZNF239 activity. For instance, agents that enhance the levels of intracellular second messenger cAMP do so by either directly activating adenylyl cyclase or inhibiting phosphodiesterases, which degrade cAMP. The elevated cAMP levels activate protein kinase A (PKA), which then phosphorylates and activates transcription factors such as CREB. Activated CREB can bind to specific DNA sequences, thereby influencing the transcriptional activity of ZNF239. Additionally, compounds that increase intracellular calcium concentrations serve as activators by triggering calcium-sensitive signaling cascades. The flux in calcium levels can activate protein kinase C (PKC), which phosphorylates various substrates that may regulate ZNF239 directly or through modulation of other transcription factors that govern its expression.
On the other side of the spectrum, inhibitors of specific kinases play a role in modulating pathways that converge on the regulation of ZNF239. Inhibition of phosphoinositide 3-kinases (PI3K) or p38 MAPK can result in alterations to downstream effectors and transcription factors, leading to changes in the regulatory network of ZNF239. Additionally, utilizing calcium chelators introduces a method to finely tune the intracellular calcium concentration, thereby indirectly influencing the activity of ZNF239 through calcium-dependent signaling mechanisms.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases intracellular levels of cAMP. ZNF239 activity is modulated via cAMP response element-binding protein (CREB), which is activated by cAMP. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
A non-selective beta-adrenergic agonist that enhances production of cAMP through the activation of adenylyl cyclase. cAMP activates CREB, which then can influence ZNF239 activity. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase 4 inhibitor, leading to an increase in cAMP levels. Higher cAMP levels result in CREB activation, which affects ZNF239 function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, which can activate calcium-sensitive signaling pathways affecting ZNF239. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore, raising intracellular calcium and potentially affecting calcium-dependent regulation of ZNF239. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Protein kinase C (PKC) activator, which can phosphorylate proteins that interact with or regulate ZNF239, leading to its functional activation. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
A non-selective inhibitor of phosphodiesterases, elevating cAMP and activating PKA, thereby influencing ZNF239 via CREB-dependent pathways. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that activates PKA and subsequently modulates CREB activity, which can influence ZNF239 function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that can lead to alterations in the AKT signaling pathway, indirectly affecting transcription factors that regulate ZNF239. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, which can alter the activity of transcription factors and signaling molecules that interact with ZNF239. | ||||||